Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.02−0.02 (-0.98%)
Close on Nov 17, 2026Market cap $191.00MP/E 5.3Yield –
Compugen price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Compugen's price to book ratio was 2.2× on Nov 11, 2026, against 2.9× a year earlier. Over the last 5 years it ranged from 0.6× to 3.6×, with a median of 2.4×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −0.6 |
| 2025 | Dec 31, 2025 | 2.8× | +0.5 |
| 2024 | Dec 31, 2024 | 2.3× | −0.5 |
| 2023 | Dec 29, 2023 | 2.8× | +2.1 |
| 2022 | Dec 30, 2022 | 0.7× | −2.8 |
| 2021 | Dec 31, 2021 | 3.5× | −4.2 |
| 2020 | Dec 31, 2020 | 7.7× | −3.9 |
| 2019 | Dec 31, 2019 | 11.6× | +8.6 |
| 2018 | Dec 31, 2018 | 3.1× | +0.4 |
| 2017 | Dec 29, 2017 | 2.7× | −0.7 |
| 2016 | Dec 30, 2016 | 3.4× | −0.0 |
| 2015 | Dec 31, 2015 | 3.4× | −0.7 |
| 2014 | Dec 31, 2014 | 4.1× | −12.5 |
| 2013 | Dec 31, 2013 | 16.6× | +8.5 |
| 2012 | Dec 31, 2012 | 8.1× | +2.2 |
| 2011 | Dec 30, 2011 | 5.9× | +0.0 |
| 2010 | Dec 31, 2010 | 5.9× | – |
See a number that looks wrong?